Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1PCAS FINLAND OY
02 1AX Pharmaceutical Corp
03 2CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD.
04 1Glenmark Life Sciences Limited
05 1LETCO MEDICAL, LLC
06 2Olon SpA
07 1Piramal Healthcare (Canada) Limited
01 3TAZAROTENE
02 6Tazarotene
01 1Canada
02 2China
03 1France
04 2India
05 2Italy
06 1U.S.A
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 51014-7755
Start Marketing Date : 2009-08-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-836
Start Marketing Date : 2008-03-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 73377-295
Start Marketing Date : 2024-10-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 48943-0027
Start Marketing Date : 2021-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0036
Start Marketing Date : 2025-01-21
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 62991-3193
Start Marketing Date : 2024-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0064
Start Marketing Date : 2016-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0065
Start Marketing Date : 2016-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55679-114
Start Marketing Date : 1996-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
45
PharmaCompass offers a list of Tazarotene API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tazarotene manufacturer or Tazarotene supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tazarotene manufacturer or Tazarotene supplier.
PharmaCompass also assists you with knowing the Tazarotene API Price utilized in the formulation of products. Tazarotene API Price is not always fixed or binding as the Tazarotene Price is obtained through a variety of data sources. The Tazarotene Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tazorac manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tazorac, including repackagers and relabelers. The FDA regulates Tazorac manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tazorac API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tazorac manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tazorac supplier is an individual or a company that provides Tazorac active pharmaceutical ingredient (API) or Tazorac finished formulations upon request. The Tazorac suppliers may include Tazorac API manufacturers, exporters, distributors and traders.
click here to find a list of Tazorac suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tazorac as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tazorac API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tazorac as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tazorac and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tazorac NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tazorac suppliers with NDC on PharmaCompass.
We have 7 companies offering Tazorac
Get in contact with the supplier of your choice:
